Ethan Dmitrovsky

20.0k citations

197 papers · 15.2k indexed · 4 hit papers · h-index 53

Impact in

Hematology top 0.2%
- Acute Myeloid Leukemia Research
Biochemistry top 0.2%
- Antioxidant Activity and Oxidative Stress

Papers in

Oncology 62
- Cancer-related Molecular Pathways 36
Hematology 24
- Acute Myeloid Leukemia Research 22

Co-authors: Sarah J. Freemantle Sutisak Kitareewan Ian Pitha Todd R. Golub Jill P. Mesirov Qing Zhu Pablo Tamayo Eric S. Lander
Journals: Cancer Research (17 papers)Oncogene (11 papers)Blood (11 papers)Molecular Cancer Therapeutics (10 papers)Journal of Clinical Oncology (10 papers)
Partner nations: United States United Kingdom France

In The Last Decade

Ethan Dmitrovsky

195 papers receiving 14.8k citations

Hit Papers

align trajectories log scale

Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation 2004 · 1.3k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2004 Genome biology
1999 Proceedings of the National Academy of Sciences
1991 New England Journal of Medicine
1991 Cell

Peers

Countries citing papers authored by Ethan Dmitrovsky

Since Specialization

Citations

This map shows the geographic impact of Ethan Dmitrovsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ethan Dmitrovsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ethan Dmitrovsky more than expected).

Fields of papers citing papers by Ethan Dmitrovsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ethan Dmitrovsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ethan Dmitrovsky. The network helps show where Ethan Dmitrovsky may publish in the future.

Co-authors

The 25 scholars most cited alongside Ethan Dmitrovsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ethan Dmitrovsky Line = papers co-authored together Ethan Dmitrovsky links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	CDK2 inhibition produces a persistent population of polyploid cancer cells JCI Insight ·Liliya Tyutyunyk‐Massey, Zibo Chen, Michael Chaikof, Masanori Kawakami, Adam Harned, Yeap Ng, Brian T. Luke, Samuel C. Okpechi, Pedro Leite‐Silva, 程妍涛, Roberto Weigert, Kedar Narayan, Xi Liu, Ethan Dmitrovsky	2025	1
2	Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival Cancer Research Communications ·Jason Roszik, J. Jack Lee, Yu‐Hung Wu, Xi Liu, Masanori Kawakami, Jonathan M. Kurie, Anas Belouali, Simina M. Boca, Samir Gupta, Robert A. Beckman, Subha Madhavan, Ethan Dmitrovsky	2022	3
3	A Novel CDK2/9 Inhibitor CYC065 Causes Anaphase Catastrophe and Represses Proliferation, Tumorigenesis, and Metastasis in Aneuploid Cancers Molecular Cancer Therapeutics ·Masanori Kawakami, Lisa Maria Mustachio, Yulong Chen, Zibo Chen, Xiuxia Liu, O Masry, Jason Roszik, Adam S. Kittai, Alexey V. Danilov, Xiaoshan Zhang, Bingliang Fang, Jing Wang, John V. Heymach, Liliya Tyutyunyk‐Massey, Sarah J. Freemantle, Jonathan M. Kurie, Xi Liu, Ethan Dmitrovsky	2020	13
4	Tyrosine Threonine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and Polyploidy Molecular Cancer Therapeutics ·Lin Zheng, Zibo Chen, Masanori Kawakami, Yulong Chen, Jason Roszik, Lisa Maria Mustachio, Jonathan M. Kurie, Pamela Villalobos, Wei Lü, Carmen Behrens, Barbara Mino, Luisa M. Solis, Jennifer Silvester, Kelsie L. Thu, David W. Cescon, Jaime Rodriguez‐Canales, Ignacio I. Wistuba, Tak W. Mak, Xi Liu, Ethan Dmitrovsky	2019	27
5	Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer Molecular Cancer Research ·Lisa Maria Mustachio, Yun Lu, Laura J. Tafe, Vincent A. Memoli, Jaime Rodriguez‐Canales, Barbara Mino, Pamela Villalobos, Ignacio I. Wistuba, Hiroyuki Katayama, Samir Hanash, Jason Roszik, Masanori Kawakami, Kwang-Jin Cho, John F. Hancock, Azizah Juliani, Shanhu Hu, Xi Liu, Sarah J. Freemantle, Ethan Dmitrovsky	2017	34
6	G0S2 represses PI3K/mTOR signaling and increases sensitivity to PI3K/mTOR pathway inhibitors in breast cancer Cell Cycle ·Christina Y. Yim, Taichi Ninomiya, 夏光涛, Sumalatha Gadam, 肇福永, Jennifer Rodriguez, Ethan Dmitrovsky, Sarah J. Freemantle, Michael J. Spinella	2017	16
7	Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin-Dependent Kinases 1 and 2 Molecular Cancer Therapeutics ·Alexey V. Danilov, Shanhu Hu, Bernardo Orr, Kristina Godek, Lisa Maria Mustachio, David Sekula, Xi Liu, Masanori Kawakami, Faye M. Johnson, Duane A. Compton, Sarah J. Freemantle, Ethan Dmitrovsky	2016	36
8	G0S2 Suppresses Oncogenic Transformation by Repressing a MYC-Regulated Transcriptional Program Cancer Research ·Christina Y. Yim, David Sekula, Sadia Sardar, Xi Liu, Sumalatha Gadam, Janice Tam, Sarah J. Freemantle, Ethan Dmitrovsky, Michael J. Spinella	2016	43
9	Specific CP110 Phosphorylation Sites Mediate Anaphase Catastrophe after CDK2 Inhibition: Evidence for Cooperation with USP33 Knockdown Molecular Cancer Therapeutics ·Shanhu Hu, Yun Lu, Bernardo Orr, Kristina Godek, Lisa Maria Mustachio, Masanori Kawakami, David Sekula, Duane A. Compton, Sarah J. Freemantle, Ethan Dmitrovsky	2015	18
10	Comparing Histone Deacetylase Inhibitor Responses in Genetically Engineered Mouse Lung Cancer Models and a Window of Opportunity Trial in Patients with Lung Cancer Molecular Cancer Therapeutics ·Tian Ma, Fabrizio Galimberti, Cherie P. Erkmen, Vincent A. Memoli, Azizah Juliani, Lorenzo F. Sempere, Jan H. Beumer, 小池幸宏, William C. Nugent, David W. Johnstone, Gregory J. Tsongalis, Jonathan M. Kurie, Hua Li, James DiRenzo, Yongli Guo, Sarah J. Freemantle, Konstantin H. Dragnev, Ethan Dmitrovsky	2013	20
11	A Retinoic Acid—Rich Tumor Microenvironment Provides Clonal Survival Cues for Tumor-Specific CD8+ T Cells Cancer Research ·Yanxia Guo, Karina Pino‐Lagos, J. Rodier, Kathy A. Bennett, Jinshan Wang, Joseph L. Napoli, Rune Blomhoff, Shanthini Sockanathan, Roshantha A.S. Chandraratna, Ethan Dmitrovsky, Mary Jo Turk, Randolph J. Noelle	2012	37
12	Evidence for the Ubiquitin Protease UBP43 as an Antineoplastic Target Molecular Cancer Therapeutics ·Yongli Guo, Azizah Juliani, Joao A. Paulo, Alexandra G. Lopez‐Aguiar, Yun Lu, Fabrizio Galimberti, Tian Ma, Qing Feng, David Sekula, Sarah J. Freemantle, Angeline S. Andrew, Vincent A. Memoli, Ethan Dmitrovsky	2012	36
13	Hedgehog-Producing Cancer Cells Respond to and Require Autocrine Hedgehog Activity Cancer Research ·Samer Singh, Zhiqiang Wang, Dennis Liang Fei, Kendall E. Black, John A. Goetz, Robert Tokhunts, Camilla Giambelli, Jezabel Rodríguez‐Blanco, Jun Long, Ethan Lee, Karoline J. Briegel, P.A. Bejarano, Ethan Dmitrovsky, Anthony J. Capobianco, David J. Robbins	2011	40
14	Bexarotene Plus Erlotinib Suppress Lung Carcinogenesis Independent of KRAS Mutations in Two Clinical Trials and Transgenic Models Cancer Prevention Research ·Konstantin H. Dragnev, Tian Ma, Michaela VÁLKOVÁ, Fabrizio Galimberti, Vincent A. Memoli, Priscila de Souza Pereira Rollo, Gregory J. Tsongalis, Marc Seltzer, David W. Johnstone, Cherie P. Erkmen, William C. Nugent, James R. Rigas, Xi Liu, Sarah J. Freemantle, Jonathan M. Kurie, Samuel Waxman, Ethan Dmitrovsky	2011	40
15	Blockade of the Ubiquitin Protease UBP43 Destabilizes Transcription Factor PML/RARα and Inhibits the Growth of Acute Promyelocytic Leukemia Cancer Research ·Yongli Guo, Joao A. Paulo, Azizah Juliani, Bruce A. Stanton, Jennifer M. Bomberger, Eugene Demidenko, Xuan-Yu Lai, Robert E. Gallagher, Tian Ma, Fabrizio Galimberti, Xi Liu, David Sekula, Sarah J. Freemantle, Ethan Dmitrovsky	2010	52
16	Targeting the Cyclin E-Cdk-2 Complex Represses Lung Cancer Growth by Triggering Anaphase Catastrophe Clinical Cancer Research ·Fabrizio Galimberti, Wirdayati Wirdayati, Xi Liu, Hua Li, Vincent A. Memoli, Simon R. Green, James DiRenzo, Patricia Greninger, Sreenath V. Sharma, Jeff Settleman, Duane A. Compton, Ethan Dmitrovsky	2009	60
17	High DNA Methyltransferase 3B Expression Mediates 5-Aza-Deoxycytidine Hypersensitivity in Testicular Germ Cell Tumors Cancer Research ·Marina Cewick, K. Toyoda, Kyung Il Kim, Sarah J. Freemantle, Alan Eastman, Ethan Dmitrovsky, Michael J. Spinella	2009	88
18	Uncovering Growth-Suppressive MicroRNAs in Lung Cancer Clinical Cancer Research ·Xi Liu, Lorenzo F. Sempere, Fabrizio Galimberti, Sarah J. Freemantle, Candice C. Black, Konstantin H. Dragnev, Yan Ma, Steven Fiering, Vincent A. Memoli, Hua Li, James DiRenzo, Murray Korc, Charles N. Cole, Mads Bak, Sakari Kauppinen, Ethan Dmitrovsky	2009	151
19	UBE1L causes lung cancer growth suppression by targeting cyclin D1 Molecular Cancer Therapeutics ·Qing Feng, David Sekula, Yongli Guo, Xi Liu, Candice C. Black, Fabrizio Galimberti, Sumit J. Shah, Lorenzo F. Sempere, Vincent A. Memoli, Jesper B. Andersen, Bret A. Hassel, Konstantin H. Dragnev, Ethan Dmitrovsky	2008	73
20	A Proof-of-Principle Clinical Trial of Bexarotene in Patients with Non–Small Cell Lung Cancer Clinical Cancer Research ·Konstantin H. Dragnev, W. Jeffrey Petty, Sumit J. Shah, Lionel D. Lewis, Candice C. Black, Vincent A. Memoli, William C. Nugent, Thomas Hermann, A. Negro‐Vilar, James R. Rigas, Ethan Dmitrovsky	2007	63

About Ethan Dmitrovsky

Ethan Dmitrovsky is a scholar working on Oncology, Hematology, Molecular Biology, Immunology and Cancer Research, having authored 197 papers that have together received 15.2k indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (82 papers), Cancer-related Molecular Pathways (36 papers), Ubiquitin and proteasome pathways (25 papers), Acute Myeloid Leukemia Research (22 papers), Lung Cancer Treatments and Mutations (20 papers), Estrogen and related hormone effects (18 papers), Microtubule and mitosis dynamics (15 papers) and Epigenetics and DNA Methylation (14 papers). The work is most often cited by research in Hematology (2.6k citations), Biochemistry (1.2k citations), Cancer Research (2.6k citations), Molecular Biology (11.7k citations) and Oncology (3.0k citations). Ethan Dmitrovsky has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Sarah J. Freemantle, Sutisak Kitareewan, Ian Pitha, Todd R. Golub, Jill P. Mesirov, Qing Zhu, Pablo Tamayo, Eric S. Lander, Donna K. Slonim and SR Frankel. Their work appears in journals such as Cancer Research, Oncogene, Blood, Molecular Cancer Therapeutics and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact